Indication
Vogt-Koyanagi-Harada Disease
2 clinical trials
1 product
1 drug
Clinical trial
Intravitreal Bevacizumab for the Treatment of Neovascular Membranes in Patients With Intraocular InflammationStatus: Withdrawn, Estimated PCD: 2006-12-01
Drug
AtezolizumabClinical trial
Influência de imunomodulação Precoce Influence of Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease: a Prospective StudyStatus: Recruiting, Estimated PCD: 2023-05-18